At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMIX Autonomix Medical Inc
Trading 10-07 09:53:35 EDT
3.53
+0.06
+1.73%
High3.53Low3.45Vol5.92K
Open3.49D1 Closing3.47Amplitude2.30%
Mkt Cap6.92MTradable Cap6.67MTotal Shares1.96M
T/O20.66KT/O Rate0.31%Tradable Shares1.89M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Autonomix announces CIPO issued patent for catheter-based tech
TIPRANKS  ·  10-02
Autonomix announces CIPO issued patent for catheter-based tech
Autonomix Medical Wins Canadian Patent for Catheter-Based Transvascular Nerve Therapy Platform
Reuters  ·  10-02
Autonomix Medical Wins Canadian Patent for Catheter-Based Transvascular Nerve Therapy Platform
Autonomix Medical - Identifies Class Ii Regulatory Pathway Using Substantial Equivalence
THOMSON REUTERS  ·  09-30
Autonomix Medical - Identifies Class Ii Regulatory Pathway Using Substantial Equivalence
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
THOMSON REUTERS  ·  09-30
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
Autonomix Medical - FDA Feedback Supports Class Ii Pathway for Autonomix Standalone Sensing Platform
THOMSON REUTERS  ·  09-30
Autonomix Medical - FDA Feedback Supports Class Ii Pathway for Autonomix Standalone Sensing Platform
Autonomix Medical - Targets U.S. Clearance for Standalone Sensing Platform in 15 Months
THOMSON REUTERS  ·  09-30
Autonomix Medical - Targets U.S. Clearance for Standalone Sensing Platform in 15 Months
Autonomix Medical Wins European Patent for Eye-Based Neural Activity Assessment System
Reuters  ·  09-24
Autonomix Medical Wins European Patent for Eye-Based Neural Activity Assessment System
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
GlobeNewswire  ·  09-24
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
THOMSON REUTERS  ·  09-16
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
Autonomix Medical Announces Annual Shareholder Meeting
Reuters  ·  09-05
Autonomix Medical Announces Annual Shareholder Meeting
Autonomix Medical Says Two Transvascular Technology Abstracts Accepted for CIRSE 2026 Posters
Reuters  ·  09-01
Autonomix Medical Says Two Transvascular Technology Abstracts Accepted for CIRSE 2026 Posters
Autonomix announces new U.S. patent
TIPRANKS  ·  08-26
Autonomix announces new U.S. patent
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
THOMSON REUTERS  ·  08-26
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
Autonomix Medical Wins New US Patent for Feedback-Guided Precision Neuromodulation Systems
Reuters  ·  08-26
Autonomix Medical Wins New US Patent for Feedback-Guided Precision Neuromodulation Systems
Top Midday Gainers
MT Newswires Live  ·  08-26
Top Midday Gainers
Autonomix Medical Investor Exercises Warrants for USD 4.9 Million in Stock Purchase###
Reuters  ·  08-25
Autonomix Medical Investor Exercises Warrants for USD 4.9 Million in Stock Purchase###
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
GlobeNewswire  ·  08-25
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) Estimate
Benzinga Earnings  ·  08-13
Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) Estimate
Autonomix Medical Q2 FY26 Net Loss Narrows 18.18% to $2.7 Million
Reuters  ·  08-13
Autonomix Medical Q2 FY26 Net Loss Narrows 18.18% to $2.7 Million
Autonomix Medical Completes Good Laboratory Practice (Glp) Preclinical Study, Marking Key Step Toward FDA Submission
THOMSON REUTERS  ·  08-12
Autonomix Medical Completes Good Laboratory Practice (Glp) Preclinical Study, Marking Key Step Toward FDA Submission

Introduction

Company Name.
Autonomix Medical Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Issue price:
--